Executive Director, Head of US Rare Endocrinology and Rare Tumors
AstraZeneca · Posted Nov 10, 2026
- Boston, Massachusetts, United States
- Full-time · Senior
- $282K–$423K per year
- 12+ years
The Executive Director, Head of US Rare Endocrinology and Rare Tumors will provide senior medical leadership and full US Medical Affairs strategic ownership for all in-country Medical Affairs activities for Alexion's Rare Endocrinology and Rare Tumors portfolio.
Compensation
The annual base pay for this position ranges from $ 282,046.40 - 423,069.60 Annual USD. Base pay offered may vary depending on multiple individualized factors, including market location, job-related knowledge, skills, and experience. In addition, our positions offer a short-term incentive bonus opportunity; eligibility to participate in our equity-based long-term incentive program.
Responsibilities
- Advance understanding of the US Rare Endocrinology and Rare Tumors medical and treatment landscape
- Lead the design and execution of the strategy and tactical plans for assigned tumors
- Serve as the senior US medical leader for the therapeutic area
- Lead and develop a high-performing Medical Affairs team
- Define portfolio priorities, resource needs, and budget planning
Requirements
- Advanced scientific or clinical degree, including M.D., PharmD, Ph.D., or equivalent advanced degree
- Nice to have: Product lifecycle management
- Nice to have: Early and late clinical development
- Nice to have: Investigator-sponsored research
- Nice to have: Senior leadership forums